Singapore markets open in 47 minutes

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.840-0.060 (-3.16%)
At close: 03:35PM HKT
Full screen
Previous close1.900
Open1.820
Bid1.840 x N/A
Ask1.940 x N/A
Day's range1.750 - 1.840
52-week range1.750 - 4.770
Volume14,800
Avg. volume38,826
Market cap462.081M
Beta (5Y monthly)-0.45
PE ratio (TTM)N/A
EPS (TTM)-0.770
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire Asia

    Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

    Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety and efficacy of the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System for the treatment of primary hypertension (NCT02901704). The study was led by Academician Runlin GAO and Professor Xiongjing JIANG from Fuwai Hos